|
ZA732136B
(en)
|
1972-04-12 |
1974-03-27 |
Lilly Co Eli |
Dopamine derivatives
|
|
DE2753278A1
(de)
*
|
1977-11-30 |
1979-05-31 |
Basf Ag |
Aralkylpiperidinone
|
|
US4321386A
(en)
|
1981-01-28 |
1982-03-23 |
Mead Johnson & Company |
Quaternary piperidinium halides
|
|
DE3222152A1
(de)
*
|
1982-06-12 |
1983-12-15 |
Bayer Ag, 5090 Leverkusen |
Substituierte maleinsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
|
DK171627B1
(da)
|
1983-01-31 |
1997-03-03 |
Lilly Co Eli |
Anvendelse af beta-phenethanolamin og farmaceutiskacceptable salte deraf samt dyrefoderpræblanding med indhold deraf
|
|
JPS62283922A
(ja)
|
1986-05-30 |
1987-12-09 |
Tsumura Juntendo Inc |
血小板凝集抑制剤
|
|
US4697024A
(en)
|
1986-11-24 |
1987-09-29 |
Merrell Dow Pharmaceuticals Inc. |
Medroxalol intermediates
|
|
US4958029A
(en)
|
1987-01-13 |
1990-09-18 |
Banyu Pharmaceutical Co., Ltd. |
Process for the production of isoindoline derivatives, novel intermediates and process for their production
|
|
JPH01180822A
(ja)
|
1988-01-12 |
1989-07-18 |
Dainippon Pharmaceut Co Ltd |
抗遅延型アレルギー剤
|
|
JPH01305085A
(ja)
*
|
1988-05-31 |
1989-12-08 |
Yamanouchi Pharmaceut Co Ltd |
ピリジルチアゾリジンカルボン酸アミド誘導体
|
|
JPH02215789A
(ja)
*
|
1989-02-15 |
1990-08-28 |
Yamanouchi Pharmaceut Co Ltd |
チアゾロ［３，４―ａ］ピラジン誘導体
|
|
EP0507863A4
(en)
|
1989-12-28 |
1993-07-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
DE4000610A1
(de)
|
1990-01-11 |
1991-07-18 |
Knoll Ag |
Verfahren zur herstellung von optisch aktiven 3-amino-1-arylbutanen und 3-benzylamino-1-arylbutanen
|
|
JP2818958B2
(ja)
|
1990-02-23 |
1998-10-30 |
塩野義製薬株式会社 |
４―（４―アルコキシフェニル）―２―ブチルアミン誘導体およびその製造法
|
|
JPH045266A
(ja)
|
1990-04-24 |
1992-01-09 |
Toyo Pharma- Kk |
ドパミン誘導体の製造方法
|
|
DE4142366A1
(de)
|
1991-07-15 |
1993-06-24 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
CN1192011C
(zh)
|
1991-08-23 |
2005-03-09 |
Nps药物有限公司 |
对钙受体具活性的芳烷基胺化合物
|
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
|
JPH06321781A
(ja)
*
|
1993-05-13 |
1994-11-22 |
Yamanouchi Pharmaceut Co Ltd |
血小板活性化因子拮抗剤
|
|
JPH0714147A
(ja)
|
1993-06-25 |
1995-01-17 |
Dainippon Printing Co Ltd |
磁気記録媒体および磁気記録媒体の記録方法
|
|
JPH07145147A
(ja)
*
|
1993-11-26 |
1995-06-06 |
Yamanouchi Pharmaceut Co Ltd |
安息香酸誘導体又はその塩
|
|
US6211244B1
(en)
|
1994-10-21 |
2001-04-03 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active compounds
|
|
DE19529411A1
(de)
|
1995-08-10 |
1997-02-13 |
Bayer Ag |
Substituierte Tetrahydro-5-nitro-pyrimidine
|
|
JP3522930B2
(ja)
|
1995-12-06 |
2004-04-26 |
花王株式会社 |
抗菌剤及びこれを含有する口腔用組成物
|
|
WO1997030038A1
(en)
|
1996-02-15 |
1997-08-21 |
Mitsubishi Chemical Corporation |
Diarylsultam derivatives
|
|
US6235731B1
(en)
|
1996-04-24 |
2001-05-22 |
Takeda Chemical Industries, Ltd. |
Fused imidazopyridine derivatives as antihyperlipidemic agents
|
|
US6218506B1
(en)
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
|
US6518315B1
(en)
|
1997-10-21 |
2003-02-11 |
The University Of Sydney |
Medicinal uses of phenylaikanols and derivatives
|
|
CO4980891A1
(es)
*
|
1997-11-14 |
2000-11-27 |
Sanofi Sa |
Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
|
|
CO5011072A1
(es)
|
1997-12-05 |
2001-02-28 |
Lilly Co Eli |
Etanolaminas pirazinil substituidas como agfonistas de los receptores
|
|
TWI244481B
(en)
|
1998-12-23 |
2005-12-01 |
Pfizer |
3-azabicyclo[3.1.0]hexane derivatives useful in therapy
|
|
IL138686A0
(en)
|
1999-10-01 |
2001-10-31 |
Pfizer Prod Inc |
α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
|
|
AU2300001A
(en)
|
1999-10-22 |
2001-05-08 |
Board Of Trustees Of The University Of Illinois, The |
Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
|
|
DE10027151A1
(de)
|
2000-05-31 |
2001-12-06 |
Bayer Ag |
Herbizide Mittel auf Basis von substituierten Carbonsäureamiden
|
|
ATE273695T1
(de)
|
2000-06-28 |
2004-09-15 |
Smithkline Beecham Plc |
Nassvermahlung
|
|
JP4329290B2
(ja)
*
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
脂肪族含窒素五員環化合物
|
|
ES2365602T3
(es)
|
2001-03-05 |
2011-10-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Proteínas oligoméricas tipo chaperona, estables a desnaturalizantes y/o resistentes a proteasa, polinucleótidos que codifican las mismas y sus usos.
|
|
JP4312402B2
(ja)
|
2001-07-31 |
2009-08-12 |
有限会社大長企画 |
抗うつ剤、抗更年期障害剤、抗老人性痴呆症剤、抗アルツハイマー剤
|
|
US20030073681A1
(en)
|
2001-08-21 |
2003-04-17 |
Hauske James R. |
2-substituted piperidines that are ligands for monoamine receptors and transporters
|
|
US6991814B2
(en)
|
2001-12-13 |
2006-01-31 |
Council Of Scientific And Industrial Research |
Herbal medicaments for the treatment of neurocerebrovascular disorders
|
|
UA82057C2
(en)
|
2001-12-14 |
2008-03-11 |
Каунсил Оф Сайентифик Энд Индастриал Рисёрч |
COMPOSITION basED on AR-D-turmeron and α- anD β-turmeron FOR TREATING NEUROCEREBROVASCULAR DISORDERS
|
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP2004002517A
(ja)
|
2002-05-31 |
2004-01-08 |
Dae Sil Kim |
生姜成分を含む石鹸の組成物及びその製造方法
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
DE10320560A1
(de)
|
2003-05-07 |
2004-01-29 |
Brosig, Stefan, Dr. |
Mittel zur Bekämpfung der Alzheimer Erkrankung und/oder der Parkinson Krankheit
|
|
US7829562B2
(en)
|
2003-06-12 |
2010-11-09 |
M's Science Corporation |
Sigma ligands for neuronal regeneration and functional recovery
|
|
US20050032827A1
(en)
|
2003-06-12 |
2005-02-10 |
Donna Oksenberg |
Sigma ligands for neuronal regeneration and functional recovery
|
|
JP2007502828A
(ja)
*
|
2003-08-21 |
2007-02-15 |
ファイザー・プロダクツ・インク |
神経変性性疾患の治療のための化合物
|
|
HRP20060326A2
(hr)
|
2004-03-12 |
2007-02-28 |
Egis Gy�gyszergy�r Nyrt. |
Kombinirani farmaceutski kompozit za inhibiciju pada kognitivnih funkcija
|
|
EP1752144A4
(en)
|
2004-05-31 |
2007-07-11 |
Kaneka Corp |
AGENT FOR PREVENTING / IMPROVING LIFESTYLE DISEASES CONTAINING AN ESSENTIAL CURCUMA OIL COMPONENT
|
|
DK1794313T3
(da)
|
2004-06-21 |
2013-07-22 |
Proteome Sciences Plc |
Fremgangsmåde til screeninger der anvender C-ABL, FYN og SYK i kombination med tau-protein
|
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
|
EP1797036A1
(en)
|
2004-09-10 |
2007-06-20 |
UCB Pharma, S.A. |
Sigma receptor ligands
|
|
WO2006047254A1
(en)
|
2004-10-22 |
2006-05-04 |
Regents Of The University Of Minnesota |
Assemblies of oligomeric amyloid beta protein and uses thereof
|
|
WO2006066118A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment
|
|
WO2006094724A2
(en)
|
2005-03-05 |
2006-09-14 |
Abbott Gmbh & Co. Kg |
Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
|
|
KR20080041624A
(ko)
|
2005-06-15 |
2008-05-13 |
대릭 에스. 에치. 엘. 김 |
베타-아밀로이드 단백질-유발 안질환의 치료 방법
|
|
TW200726774A
(en)
|
2005-06-30 |
2007-07-16 |
Merck & Co Inc |
Composition and method for producing stable amyloid beta oligomers
|
|
EP1745778A3
(en)
|
2005-07-20 |
2007-03-07 |
Speedel Experimenta AG |
Diaminoalcohols as therapeutic compounds
|
|
ITRM20060007A1
(it)
|
2006-01-05 |
2007-07-06 |
Univ Bari |
Recettore sigma-2 metodo di screening di ligandi specifici e uso degli stessi in metodi diagnostici o terapeutici
|
|
US20070218491A1
(en)
|
2006-02-08 |
2007-09-20 |
Oligomerix, Inc. |
Oligomerization of amyloid proteins
|
|
CA2644093A1
(en)
|
2006-03-17 |
2007-09-27 |
Herbalscience Singapore Pte. Ltd. |
Extracts and methods comprising curcuma species
|
|
US20100029654A1
(en)
|
2006-03-23 |
2010-02-04 |
Mount Sinai School Of Medicine |
Cardiovascular compositions and use of the same for the treatment of alzheimer's disease
|
|
WO2007126473A2
(en)
|
2006-04-10 |
2007-11-08 |
Oligomerix, Inc. |
Oligomerization of amyloid proteins
|
|
US8357781B2
(en)
|
2006-06-01 |
2013-01-22 |
Janssen Alzheimer Immunotherapy |
Neuroactive fragments of APP
|
|
US7561775B2
(en)
|
2006-08-22 |
2009-07-14 |
Senko Advanced Components, Inc. |
Fiber optic protective shutter
|
|
US20100093001A1
(en)
|
2006-09-08 |
2010-04-15 |
Frederic Rousseau |
Means and methods for the production of amyloid oligomers
|
|
WO2008042755A2
(en)
|
2006-09-29 |
2008-04-10 |
Cognition Therapeutics, Inc. |
Inhibitors of cognitive decline
|
|
US20080131233A1
(en)
|
2006-10-17 |
2008-06-05 |
Yao Chun I |
Plate-shaped fastener device
|
|
US20100028333A1
(en)
|
2006-12-15 |
2010-02-04 |
Getty Krista L |
Receptor for amyloid beta and uses thereof
|
|
EP2152744A4
(en)
|
2007-04-26 |
2012-02-15 |
Univ Yale |
PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS
|
|
KR20100029079A
(ko)
|
2007-05-15 |
2010-03-15 |
헬리콘 테라퓨틱스 인코퍼레이티드 |
Ｇｐｒ12의 저해로 인지 질환을 치료하는 방법
|
|
CN101121670A
(zh)
|
2007-09-11 |
2008-02-13 |
上海紫源制药有限公司 |
一种3,4-二甲氧基-N-[3-(4-甲氧基苯基)-1-甲基-正丙基]-β-苯乙胺盐酸盐的制备方法
|
|
US20090246191A1
(en)
|
2007-10-11 |
2009-10-01 |
University Of Tennessee Research Foundation |
Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
|
|
RU2461551C2
(ru)
|
2007-10-24 |
2012-09-20 |
Астеллас Фарма Инк. |
Азолкарбоксамидное соединение или его фармацевтически приемлемая соль
|
|
US8168800B2
(en)
|
2007-11-02 |
2012-05-01 |
The Regents Of The University Of California |
Aβ-binding small molecules
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
JP2011529084A
(ja)
|
2008-07-25 |
2011-12-01 |
アボット・ラボラトリーズ |
アミロイドβペプチド類似体、これらのオリゴマー、前記類似体またはオリゴマーを調製するためのプロセスおよび前記類似体またはオリゴマーを含む組成物ならびにこれらの使用
|
|
WO2010062260A1
(en)
|
2008-11-29 |
2010-06-03 |
The Thailand Research Fund |
Virus and target cell interaction inhibition
|
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
|
MX2011008450A
(es)
|
2009-02-10 |
2011-09-01 |
Abbott Lab |
Agonistas y antagonistas del receptor s1p5, y metodos de uso de los mismos.
|
|
EP2408905B1
(en)
|
2009-03-16 |
2017-05-10 |
Pangu Biopharma Limited |
Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
|
|
SG10201404913QA
(en)
|
2009-04-09 |
2014-11-27 |
Cognition Therapeutics Inc |
Inhibitors of cognitive decline
|
|
US9493834B2
(en)
|
2009-07-29 |
2016-11-15 |
Pharnext |
Method for detecting a panel of biomarkers
|
|
RU2012107457A
(ru)
|
2009-07-31 |
2013-09-10 |
Когнишн Терапьютикс, Инк. |
Ингибиторы ухудшения когнитивных способностей
|
|
US20150160228A1
(en)
|
2010-02-05 |
2015-06-11 |
Susan Catalano |
Compositions and method for determining the efficacy of amyloidosis treatments
|
|
US20130071330A1
(en)
|
2010-02-26 |
2013-03-21 |
Susan Catalano |
Methods of identifying agents effective to treat cognitive decline and diseases associated therewith
|
|
WO2012027548A1
(en)
|
2010-08-25 |
2012-03-01 |
The Feinstein Institute For Medical Research |
Compounds and methods for prevention and treatment of alzheimer's and other diseases
|
|
US9499462B2
(en)
|
2011-02-02 |
2016-11-22 |
Cognition Therapeutics, Inc. |
Isolated compounds from turmeric oil and methods of use
|
|
CA2846611A1
(en)
|
2011-08-25 |
2013-02-28 |
Cognition Therapeutics, Inc. |
Compositions and methods for treating neurodegenerative disease
|
|
RU2014111079A
(ru)
*
|
2011-08-25 |
2015-09-27 |
Когнишн Терапьютикс, Инк. |
Композиции и способы для лечения нейродегенеративного заболевания
|
|
WO2015020523A1
(en)
|
2013-08-07 |
2015-02-12 |
Stichting Vu-Vumc |
Biomarkers for early diagnosis of alzheimer's disease
|
|
DK3099296T3
(en)
|
2014-01-31 |
2019-04-15 |
Cognition Therapeutics Inc |
ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
|
|
EP3634394B1
(en)
*
|
2017-05-15 |
2025-12-24 |
Cognition Therapeutics, Inc. |
Compositions for treating neurodegenerative diseases
|
|
EP3704092A4
(en)
|
2017-11-01 |
2021-08-25 |
Cognition Therapeutics, Inc. |
ISOINDOLINE COMPOSITIONS AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISEASE
|
|
CN110283082A
(zh)
|
2019-07-15 |
2019-09-27 |
泰州职业技术学院 |
一种3-苯基丙胺的制备方法
|
|
WO2022125925A1
(en)
|
2020-12-11 |
2022-06-16 |
Cognition Therapeutics, Inc. |
Compositions for treating dry age-related macular degeneration (amd)
|